Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Möller P[au]:

Search results

Items: 1 to 50 of 1583

1.

Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma.

Gehringer F, Weissinger SE, Möller P, Wirth T, Ushmorov A.

Leukemia. 2019 Nov 12. doi: 10.1038/s41375-019-0628-0. [Epub ahead of print]

PMID:
31719683
2.

Localized and Advanced Stage Follicular Lymphomas Differ in their Gene Expression Profiles.

Staiger AM, Hoster E, Jurinovic V, Winter S, Leich E, Kalla C, Möller P, Bernd HW, Feller AC, Koch K, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Weigert O, Hiddemann W, Herfarth K, Rosenwald A, Engelhard M, Ott G, Horn H.

Blood. 2019 Oct 10. pii: blood.2019000560. doi: 10.1182/blood.2019000560. [Epub ahead of print]

PMID:
31697802
3.

Assessment of Exudative Activity of Choroidal Neovascularization in Age-Related Macular Degeneration by OCT Angiography.

von der Emde L, Thiele S, Pfau M, Nadal J, Meyer J, Möller PT, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg S.

Ophthalmologica. 2019 Oct 30:1-9. doi: 10.1159/000503609. [Epub ahead of print]

PMID:
31665719
4.

Consequences of marine barriers for genetic diversity of the coral-specialist yellowbar angelfish from the Northwestern Indian Ocean.

Torquato F, Range P, Ben-Hamadou R, Sigsgaard EE, Thomsen PF, Riera R, Berumen ML, Burt JA, Feary DA, Marshell A, D'Agostino D, DiBattista JD, Møller PR.

Ecol Evol. 2019 Sep 4;9(19):11215-11226. doi: 10.1002/ece3.5622. eCollection 2019 Oct.

5.

Age- and BMI-Associated Expression of Angiogenic Factors in White Adipose Tissue of Children.

Gaebler N, Haggenmüller B, Kapapa M, Serra A, Tews D, Funcke JB, Brandt S, Ioannidis V, Schön M, Möller P, Debatin KM, Wabitsch M, Fischer-Posovszky P.

Int J Mol Sci. 2019 Oct 21;20(20). pii: E5204. doi: 10.3390/ijms20205204.

6.

Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.

Dominguez-Valentin M, Seppälä TT, Sampson JR, Macrae F, Winship I, Evans DG, Scott RJ, Burn J, Möslein G, Bernstein I, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lindblom A, Plazzer JP, Tjandra D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Vidal JB, Rønlund K, Nielsen RT, Yilmaz M, Elvang LL, Katz L, Nielsen M, Ten Broeke SW, Nakken S, Hovig E, Sunde L, Kloor M, Knebel Doeberitz MV, Ahadova A, Lindor N, Steinke-Lange V, Holinski-Feder E, Mecklin JP, Møller P.

Hered Cancer Clin Pract. 2019 Oct 14;17:28. doi: 10.1186/s13053-019-0127-3. eCollection 2019.

7.

Caregivers' Need for Support in an Outpatient Cancer Setting.

Andersen NI, Nielsen CI, Danbjørg DB, Møller PK, Brochstedt KD.

Oncol Nurs Forum. 2019 Nov 1;46(6):757-767. doi: 10.1188/19.ONF.757-767.

PMID:
31626607
8.

Light Sensitivity Within Areas of Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Pfau M, von der Emde L, Dysli C, Thiele S, Möller PT, Lindner M, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M.

Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3992-4001. doi: 10.1167/iovs.19-27178.

PMID:
31560765
9.

FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma.

Gehringer F, Weissinger SE, Swier LJ, Möller P, Wirth T, Ushmorov A.

Cancers (Basel). 2019 Sep 25;11(10). pii: E1427. doi: 10.3390/cancers11101427.

10.

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL.

Staiger AM, Altenbuchinger M, Ziepert M, Kohler C, Horn H, Huttner M, Hüttl KS, Glehr G, Klapper W, Szczepanowski M, Richter J, Stein H, Feller AC, Möller P, Hansmann ML, Poeschel V, Held G, Loeffler M, Schmitz N, Trümper L, Pukrop T, Rosenwald A, Ott G, Spang R; Emed Demonstrator Project; German High Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL).

Leukemia. 2019 Sep 17. doi: 10.1038/s41375-019-0573-y. [Epub ahead of print]

PMID:
31530861
11.

Dataset of clinical, immunohistopathological and laboratory features of patients with MHC II deficiency suffering from enteropathy.

Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Schütz C, Hönig M, Debatin KM, Schulz A, Möller P, Barth TF.

Data Brief. 2019 Aug 28;26:104446. doi: 10.1016/j.dib.2019.104446. eCollection 2019 Oct.

12.

Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer.

Doescher J, Weissinger SE, Schönsteiner SS, Lisson C, Bullinger L, Barth TF, Leithäuser F, Mueller-Richter U, Laban S, Hoffmann TK, Möller P, Lennerz JK, Schuler PJ.

Immunotherapy. 2019 Oct;11(14):1193-1203. doi: 10.2217/imt-2019-0041. Epub 2019 Aug 29.

PMID:
31462115
13.

Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.

Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende CC, Dyckhoff G, Boscolo-Rizzo P, Ezić J, Marienfeld R, Möller P, Kraus JM, Völkel G, Kestler HA, Brunner C, Schuler PJ, Wigand MC, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Waterboer T, Butt J.

Clin Cancer Res. 2019 Aug 23. doi: 10.1158/1078-0432.CCR-19-1490. [Epub ahead of print]

PMID:
31444248
14.

A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries.

Della Valle A, Rossi BM, Palmero EI, Antelo M, Vaccaro CA, López-Kostner F, Alvarez K, Cruz-Correa M, Bruno LI, Forones NM, Mindiola JAR, Buleje J, Spirandelli F, Bohorquez M, Cock-Rada AM, Sullcahuaman Y, Nascimento I, Abe-Sandes K, Lino-Silva LS, Petracchi F, Mampel A, Rodriguez Y, Rossi NT, Yañez CB, Rubio C, Petta-Lajus TB, Silveira-Lucas EL, Jiménez G, Peña CMM, Reyes-Silva C, Ayala-Madrigal ML, Del Monte JS, Quispe R, Recalde A, Neffa F, Sarroca C, de Campos Reis Galvão H, Golubicki M, Piñero TA, Kalfayan PG, Ferro FA, Gonzalez ML, Pérez-Mayoral J, Pimenta CAM, Uyaban SPB, Protzel A, Chávez G, Dueñas M, Gil MLG, Spirandelli E, Chialina S, Echeverry M, Fuenmayor LJP, Torres M, Palma TFB, Héritas NC, Martin C, Suárez A, Vallejo M, Rafaela de Souza Timoteo A, Ayala CA, Jaramillo-Koupermann G, Hernández-Sandoval JA, Guerrero AH, Dominguez-Barrera C, Bazo-Alvarez JC, Wernhoff P, Plazzer JP, Balavarca Y, Hovig E, Møller P, Dominguez-Valentin M; collaboration with LA-GETH.

Eur J Cancer. 2019 Sep;119:112-121. doi: 10.1016/j.ejca.2019.07.017. Epub 2019 Aug 20.

PMID:
31442815
15.

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome.

Richter J, Hüttmann A, Rekowski J, Schmitz C, Gärtner S, Rosenwald A, Hansmann ML, Hartmann S, Möller P, Wacker HH, Feller A, Thorns C, Müller S, Dührsen U, Klapper W.

Blood Cancer J. 2019 Aug 19;9(9):67. doi: 10.1038/s41408-019-0230-8. No abstract available.

16.

Fish and salad consumption are inversely associated with levels of oxidatively damaged DNA in a Danish adult cohort.

Møller P, Jensen A, Løhr M, Eriksen L, Grønbæk M, Loft S.

Mutat Res. 2019 Jul;843:66-72. doi: 10.1016/j.mrgentox.2018.11.003. Epub 2018 Nov 20.

PMID:
31421741
17.

Technical recommendations to perform the alkaline standard and enzyme-modified comet assay in human biomonitoring studies.

Azqueta A, Muruzabal D, Boutet-Robinet E, Milic M, Dusinska M, Brunborg G, Møller P, Collins AR.

Mutat Res. 2019 Jul;843:24-32. doi: 10.1016/j.mrgentox.2019.04.007. Epub 2019 May 1.

PMID:
31421734
18.

Basic self-disturbances independently predict recovery in psychotic disorders: A seven year follow-up study.

Svendsen IH, Øie MG, Møller P, Nelson B, Haug E, Melle I.

Schizophr Res. 2019 Oct;212:72-78. doi: 10.1016/j.schres.2019.08.009. Epub 2019 Aug 14.

PMID:
31420200
19.

DNA repair as a human biomonitoring tool: Comet assay approaches.

Azqueta A, Langie SAS, Boutet-Robinet E, Duthie S, Ladeira C, Møller P, Collins AR, Godschalk RWL; Working Group 5 of the hCOMET project (CA15132).

Mutat Res. 2019 Jul - Sep;781:71-87. doi: 10.1016/j.mrrev.2019.03.002. Epub 2019 Mar 6. Review.

PMID:
31416580
20.

Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.

Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus JM, Kestler HA, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Doescher J, Hoffmann TK, Pawlita M, Butt J, Waterboer T, Laban S.

Int J Cancer. 2019 Dec 15;145(12):3436-3444. doi: 10.1002/ijc.32623. Epub 2019 Aug 26.

PMID:
31407331
21.

The impact of SOCS1 mutations in diffuse large B-cell lymphoma.

Mellert K, Martin M, Lennerz JK, Lüdeke M, Staiger AM, Kreuz M, Löffler M, Schmitz N, Trümper L, Feller AC, Hartmann S, Hansmann ML, Klapper W, Stein H, Rosenwald A, Ott G, Ziepert M, Möller P.

Br J Haematol. 2019 Aug 12. doi: 10.1111/bjh.16147. [Epub ahead of print]

PMID:
31407320
22.

The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma.

Hartmann S, Plütschow A, Mottok A, Bernd HW, Feller AC, Ott G, Cogliatti S, Fend F, Quintanilla-Martinez L, Stein H, Klapper W, Möller P, Rosenwald A, Engert A, Hansmann ML, Eichenauer DA.

Am J Hematol. 2019 Nov;94(11):1208-1213. doi: 10.1002/ajh.25607. Epub 2019 Aug 21.

PMID:
31396979
23.

Data set on sedimentology, palaeoecology and chronology of middle to late pleistocene deposits on the Taimyr Peninsula, Arctic Russia.

Möller P, Benediktsson ÍÖ, Anjar J, Bennike O, Bernhardson M, Funder S, Håkansson LM, Lemdahl G, Licciardi JM, Murray AS, Seidenkrantz MS.

Data Brief. 2019 Jul 17;25:104267. doi: 10.1016/j.dib.2019.104267. eCollection 2019 Aug.

24.

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration.

von der Emde L, Pfau M, Dysli C, Thiele S, Möller PT, Lindner M, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg S.

Sci Rep. 2019 Jul 31;9(1):11132. doi: 10.1038/s41598-019-47565-y.

25.

Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.

Værnes TG, Røssberg JI, Møller P.

Compr Psychiatry. 2019 Aug;93:65-72. doi: 10.1016/j.comppsych.2019.07.003. Epub 2019 Jul 13.

26.

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.

Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, Burn J, Greenblatt M, Hovig E, de Vos Tot Nederveen Cappel WH, Sijmons RH, Bertario L, Tibiletti MG, Cavestro GM, Lindblom A, Della Valle A, Lopez-Köstner F, Gluck N, Katz LH, Heinimann K, Vaccaro CA, Büttner R, Görgens H, Holinski-Feder E, Morak M, Holzapfel S, Hüneburg R, Knebel Doeberitz MV, Loeffler M, Rahner N, Schackert HK, Steinke-Lange V, Schmiegel W, Vangala D, Pylvänäinen K, Renkonen-Sinisalo L, Hopper JL, Win AK, Haile RW, Lindor NM, Gallinger S, Le Marchand L, Newcomb PA, Figueiredo JC, Thibodeau SN, Wadt K, Therkildsen C, Okkels H, Ketabi Z, Moreira L, Sánchez A, Serra-Burriel M, Pineda M, Navarro M, Blanco I, Green K, Lalloo F, Crosbie EJ, Hill J, Denton OG, Frayling IM, Rødland EA, Vasen H, Mints M, Neffa F, Esperon P, Alvarez K, Kariv R, Rosner G, Pinero TA, Gonzalez ML, Kalfayan P, Tjandra D, Winship IM, Macrae F, Möslein G, Mecklin JP, Nielsen M, Møller P.

Genet Med. 2019 Jul 24. doi: 10.1038/s41436-019-0596-9. [Epub ahead of print]

PMID:
31337882
27.

Reply to "What if what you are looking for is not there?" and "Towards a functional definition of euvolemia".

Moller PW, Berger D.

J Appl Physiol (1985). 2019 Jul 1;127(1):276. doi: 10.1152/japplphysiol.00229.2019. No abstract available.

PMID:
31328619
28.

Measurement of DNA damage with the comet assay in high-prevalence diseases: current status and future directions.

Møller P, Stopper H, Collins AR.

Mutagenesis. 2019 Jul 11. pii: gez018. doi: 10.1093/mutage/gez018. [Epub ahead of print]

PMID:
31294794
29.

The mechanism-based toxicity screening of particles with use in the food and nutrition sector via the ToxTracker reporter system.

Brown DM, Danielsen PH, Derr R, Moelijker N, Fowler P, Stone V, Hendriks G, Møller P, Kermanizadeh A.

Toxicol In Vitro. 2019 Dec;61:104594. doi: 10.1016/j.tiv.2019.104594. Epub 2019 Jul 4.

PMID:
31279906
30.

First clinical experiences with a high field 1.5 T MR linac.

Bertelsen AS, Schytte T, Møller PK, Mahmood F, Riis HL, Gottlieb KL, Agergaard SN, Dysager L, Hansen O, Gornitzka J, Veldhuizen E, ODwyer DB, Christiansen RL, Nielsen M, Jensen HR, Brink C, Bernchou U.

Acta Oncol. 2019 Oct;58(10):1352-1357. doi: 10.1080/0284186X.2019.1627417. Epub 2019 Jun 26.

PMID:
31241387
31.

Portal hyperperfusion after major liver resection and associated sinusoidal damage is a therapeutic target to protect the remnant liver.

Kohler A, Moller PW, Frey S, Tinguely P, Candinas D, Obrist D, Jakob SM, Beldi G.

Am J Physiol Gastrointest Liver Physiol. 2019 Sep 1;317(3):G264-G274. doi: 10.1152/ajpgi.00113.2019. Epub 2019 Jun 19.

PMID:
31216172
32.

[Subcutaneous foreign body granuloma after neck dissection and adjuvant radiation].

Mytilineos D, Hoffmann TK, Brunner C, Weißinger S, Möller P, Doescher J.

HNO. 2019 Jun 11. doi: 10.1007/s00106-019-0700-0. [Epub ahead of print] German.

PMID:
31187149
33.

Health effects of exposure to diesel exhaust in diesel-powered trains.

Andersen MHG, Frederiksen M, Saber AT, Wils RS, Fonseca AS, Koponen IK, Johannesson S, Roursgaard M, Loft S, Møller P, Vogel U.

Part Fibre Toxicol. 2019 Jun 11;16(1):21. doi: 10.1186/s12989-019-0306-4.

34.
35.

A modular transcriptome map of mature B cell lymphomas.

Loeffler-Wirth H, Kreuz M, Hopp L, Arakelyan A, Haake A, Cogliatti SB, Feller AC, Hansmann ML, Lenze D, Möller P, Müller-Hermelink HK, Fortenbacher E, Willscher E, Ott G, Rosenwald A, Pott C, Schwaenen C, Trautmann H, Wessendorf S, Stein H, Szczepanowski M, Trümper L, Hummel M, Klapper W, Siebert R, Loeffler M, Binder H; German Cancer Aid consortium Molecular Mechanisms for Malignant Lymphoma.

Genome Med. 2019 Apr 30;11(1):27. doi: 10.1186/s13073-019-0637-7.

36.

Persisting enteropathy and disturbed adaptive mucosal immunity due to MHC class II deficiency.

Posovszky C, Sirin M, Jacobsen E, Lorenz M, Schwarz K, Schmidt-Choudhury A, Rothoeft T, Schuetz C, Hönig M, Debatin KM, Schulz A, Möller P, Barth TF.

Clin Immunol. 2019 Jun;203:125-133. doi: 10.1016/j.clim.2019.04.012. Epub 2019 Apr 24.

PMID:
31028919
37.

Characterization of Three Novel H3F3A-mutated Giant Cell Tumor Cell Lines and Targeting of Their Wee1 Pathway.

Lübbehüsen C, Lüke J, Seeling C, Mellert K, Marienfeld R, von Baer A, Schultheiss M, Möller P, Barth TFE.

Sci Rep. 2019 Apr 23;9(1):6458. doi: 10.1038/s41598-019-42611-1.

38.

Variant classification in precision oncology.

Leichsenring J, Horak P, Kreutzfeldt S, Heining C, Christopoulos P, Volckmar AL, Neumann O, Kirchner M, Ploeger C, Budczies J, Heilig CE, Hutter B, Fröhlich M, Uhrig S, Kazdal D, Allgäuer M, Harms A, Rempel E, Lehmann U, Thomas M, Pfarr N, Azoitei N, Bonzheim I, Marienfeld R, Möller P, Werner M, Fend F, Boerries M, von Bubnoff N, Lassmann S, Longerich T, Bitzer M, Seufferlein T, Malek N, Weichert W, Schirmacher P, Penzel R, Endris V, Brors B, Klauschen F, Glimm H, Fröhling S, Stenzinger A.

Int J Cancer. 2019 Dec 1;145(11):2996-3010. doi: 10.1002/ijc.32358. Epub 2019 May 21.

PMID:
31008532
39.

International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation.

Metcalfe K, Eisen A, Senter L, Armel S, Bordeleau L, Meschino WS, Pal T, Lynch HT, Tung NM, Kwong A, Ainsworth P, Karlan B, Moller P, Eng C, Weitzel JN, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group.

Br J Cancer. 2019 Jul;121(1):15-21. doi: 10.1038/s41416-019-0446-1. Epub 2019 Apr 11.

PMID:
30971774
40.

Spawning by the European eel across 2000 km of the Sargasso Sea.

Miller MJ, Westerberg H, Sparholt H, Wysujack K, Sørensen SR, Marohn L, Jacobsen MW, Freese M, Ayala DJ, Pohlmann JD, Svendsen JC, Watanabe S, Andersen L, Møller PR, Tsukamoto K, Munk P, Hanel R.

Biol Lett. 2019 Apr 26;15(4):20180835. doi: 10.1098/rsbl.2018.0835.

PMID:
30966898
41.

Influence of chlorides and phosphates on the antiadhesive, antibacterial, and electrochemical properties of an electroplated copper-silver alloy.

Ciacotich N, Kilstrup M, Møller P, Gram L.

Biointerphases. 2019 Apr 9;14(2):021005. doi: 10.1116/1.5088936.

PMID:
30966754
42.

[Percutaneous cholecystostomy as treatment for acute cholecystitis at Landspitali University Hospital 2010 - 2016].

Hjaltadottir K, Haraldsdottir KH, Hannesson PH, Moller PH.

Laeknabladid. 2019 Apr;105(4):171-176. doi: 10.17992/lbl.2019.04.226. Icelandic.

43.

Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.

López C, Kleinheinz K, Aukema SM, Rohde M, Bernhart SH, Hübschmann D, Wagener R, Toprak UH, Raimondi F, Kreuz M, Waszak SM, Huang Z, Sieverling L, Paramasivam N, Seufert J, Sungalee S, Russell RB, Bausinger J, Kretzmer H, Ammerpohl O, Bergmann AK, Binder H, Borkhardt A, Brors B, Claviez A, Doose G, Feuerbach L, Haake A, Hansmann ML, Hoell J, Hummel M, Korbel JO, Lawerenz C, Lenze D, Radlwimmer B, Richter J, Rosenstiel P, Rosenwald A, Schilhabel MB, Stein H, Stilgenbauer S, Stadler PF, Szczepanowski M, Weniger MA, Zapatka M, Eils R, Lichter P, Loeffler M, Möller P, Trümper L, Klapper W; ICGC MMML-Seq Consortium, Hoffmann S, Küppers R, Burkhardt B, Schlesner M, Siebert R.

Nat Commun. 2019 Mar 29;10(1):1459. doi: 10.1038/s41467-019-08578-3.

44.

The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome.

Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, Crawford R, Eccles D, Frayling IM, Ghaem-Maghami S, Hampel H, Kauff ND, Kitchener HC, Kitson SJ, Manchanda R, McMahon RFT, Monahan KJ, Menon U, Møller P, Möslein G, Rosenthal A, Sasieni P, Seif MW, Singh N, Skarrott P, Snowsill TM, Steele R, Tischkowitz M; Manchester International Consensus Group, Evans DG.

Genet Med. 2019 Oct;21(10):2390-2400. doi: 10.1038/s41436-019-0489-y. Epub 2019 Mar 28.

45.

Exposure to Air Pollution inside Electric and Diesel-Powered Passenger Trains.

Andersen MHG, Johannesson S, Fonseca AS, Clausen PA, Saber AT, Roursgaard M, Loeschner K, Koponen IK, Loft S, Vogel U, Møller P.

Environ Sci Technol. 2019 Apr 16;53(8):4579-4587. doi: 10.1021/acs.est.8b06980. Epub 2019 Apr 5.

PMID:
30917278
46.

Addressing the room for improvement in management of acute promyelocytic leukemia.

Nørgaard JM, Friis LS, Kristensen JS, Severinsen MT, Mølle I, Marcher CW, Møller P, Schoellkopf C, Nielsen OJ, Preiss BS, Andersen MK, Kjeldsen E, Medeiros BC, Østgård LSG; Danish Acute Leukemia Group.

Eur J Haematol. 2019 Jun;102(6):479-485. doi: 10.1111/ejh.13229. Epub 2019 Apr 7.

PMID:
30887583
47.

The RNase YbeY Is Vital for Ribosome Maturation, Stress Resistance, and Virulence of the Natural Genetic Engineer Agrobacterium tumefaciens.

Möller P, Busch P, Sauerbrei B, Kraus A, Förstner KU, Wen TN, Overlöper A, Lai EM, Narberhaus F.

J Bacteriol. 2019 May 8;201(11). pii: e00730-18. doi: 10.1128/JB.00730-18. Print 2019 Jun 1.

48.

Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.

Alosaimi MF, Hoenig M, Jaber F, Platt CD, Jones J, Wallace J, Debatin KM, Schulz A, Jacobsen E, Möller P, Shamseldin HE, Abdulwahab F, Ibrahim N, Alardati H, Almuhizi F, Abosoudah IF, Basha TA, Chou J, Alkuraya FS, Geha RS.

J Allergy Clin Immunol. 2019 Aug;144(2):574-583.e5. doi: 10.1016/j.jaci.2019.03.002. Epub 2019 Mar 11.

PMID:
30872117
49.

Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).

Reinartz G, Pyra RP, Lenz G, Liersch R, Stüben G, Micke O, Willborn K, Hess CF, Probst A, Fietkau R, Jany R, Schultze J, Rübe C, Hirt C, Fischbach W, Bentz M, Daum S, Pott C, Tiemann M, Möller P, Neubauer A, Wilhelm M, Willich N, Berdel WE, Eich HT.

Strahlenther Onkol. 2019 Jun;195(6):544-557. doi: 10.1007/s00066-019-01446-5. Epub 2019 Mar 11.

PMID:
30859254
50.

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report.

Seppälä TT, Ahadova A, Dominguez-Valentin M, Macrae F, Evans DG, Therkildsen C, Sampson J, Scott R, Burn J, Möslein G, Bernstein I, Holinski-Feder E, Pylvänäinen K, Renkonen-Sinisalo L, Lepistö A, Lautrup CK, Lindblom A, Plazzer JP, Winship I, Tjandra D, Katz LH, Aretz S, Hüneburg R, Holzapfel S, Heinimann K, Valle AD, Neffa F, Gluck N, de Vos Tot Nederveen Cappel WH, Vasen H, Morak M, Steinke-Lange V, Engel C, Rahner N, Schmiegel W, Vangala D, Thomas H, Green K, Lalloo F, Crosbie EJ, Hill J, Capella G, Pineda M, Navarro M, Blanco I, Ten Broeke S, Nielsen M, Ljungmann K, Nakken S, Lindor N, Frayling I, Hovig E, Sunde L, Kloor M, Mecklin JP, Kalager M, Møller P.

Hered Cancer Clin Pract. 2019 Feb 28;17:8. doi: 10.1186/s13053-019-0106-8. eCollection 2019.

Supplemental Content

Loading ...
Support Center